Virtual Cell Models

The initiative aims to create virtual cell models that can accurately predict how cells respond to various perturbations, such as drugs, genetic edits, or environmental stress. This will enable researchers to simulate and test the effects of different treatments, potentially leading to faster and more accurate drug development.

Open Science with a Commercial Asterisk

The program follows an 'open science' approach, with data produced by the initiative intended to become publicly available. However, commercial backers may receive embargo periods before the data goes public.

Why Drug Developers Are Paying Attention

The stated goal is to speed up drug development dramatically, cutting timelines from decades to approximately 5 years. This is particularly relevant for companies working on life-saving treatments, where every year counts.

The Players Involved

Google DeepMind, Meta, and Isomorphic Labs are collectively contributing $300 million to the initiative. The US Department of Energy is committing over $500 million, and the National Institutes of Health is coordinating existing federally funded work. This is not a purely private venture, but rather a collaboration between industry and government.